Page last updated: 2024-10-25

deferoxamine and Pyelonephritis

deferoxamine has been researched along with Pyelonephritis in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Pyelonephritis: Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, R1
Gupta, S1
Joshi, K1
Ganguly, NK1
Dittrich, P1
Huber, H1
Stühlinger, W1

Other Studies

2 other studies available for deferoxamine and Pyelonephritis

ArticleYear
Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis.
    Comparative immunology, microbiology and infectious diseases, 1997, Volume: 20, Issue:4

    Topics: Animals; Chelation Therapy; Chronic Disease; Citric Acid; Deferoxamine; Disease Models, Animal; Drug

1997
[Studies on clearance of Fe59-tagged desferrioxamine in healthy kidney function and kidney diseases].
    Wiener klinische Wochenschrift, 1966, Jul-01, Volume: 78, Issue:26

    Topics: Aminohippuric Acids; Deferoxamine; Glomerulonephritis; Humans; Iron Isotopes; Kidney; Kidney Functio

1966